key: cord-0933151-oiu9b8mu
authors: Nahum, Ari; Drekonja, Dimitri M; Alpern, Jonathan D
title: The Erosion of Public Trust and SARS-CoV-2 Vaccines— More Action is Needed
date: 2021-01-04
journal: Open Forum Infect Dis
DOI: 10.1093/ofid/ofaa657
sha: f4a0b95c0f21102572bc6c70b7cc88b52b375c97
doc_id: 933151
cord_uid: oiu9b8mu

As states and health systems prepare to deliver SARS-CoV-2 vaccines to the American public, a confluence of factors has the potential to interfere with these efforts: Misinformation about COVID-19, vaccine hesitancy, and the erosion of the American public’s trust in the vaccine regulatory process due to recent and ongoing events. Broad action is needed to address these issues, including improved and consistent communication by the Food and Drug Administration, restoration of the Centers for Disease Control as an independent and science-driven institution, and more aggressive policies to counteract misinformation, particularly on social media platforms.

M a n u s c r i p t 2 Abstract:

As states and health systems prepare to deliver SARS-CoV-2 vaccines to the American public, a confluence of factors has the potential to interfere with these efforts: Misinformation about COVID-19, vaccine hesitancy, and the erosion of the American public's trust in the vaccine regulatory process due to recent and ongoing events. Broad action is needed to address these issues, including improved and consistent communication by the Food and Drug Administration, restoration of the Centers for Disease Control as an independent and science-driven institution, and more aggressive policies to counteract misinformation, particularly on social media platforms.

A c c e p t e d M a n u s c r i p t 3 News that two mRNA-based vaccines against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) were highly effective based on interim phase 3 analysis has been met with newfound optimism in a world reeling from COVID-19. A safe and effective vaccine against SARS-CoV-2 would signal a key inflection point in the pandemic. While the recent focus has understandably been on the complex logistical challenges associated with mass vaccination, the erosion of Americans' trust in the regulatory process surrounding SARS-CoV-2 vaccines may prove to be a greater obstacle.

In February, less than one month before the World Health Organization (WHO) declared the SARS-CoV-2 outbreak a pandemic, the WHO called attention to an alarming amount of misinformation about COVID-19 circulating globally. Since that time, COVID misinformation has continued to grow primarily through social media platforms (SMPs), 1 and is diverse in both scope and appeal. Discouragingly, many false or misleading claims have originated from the statements of public authorities. Although such -top down‖ misinformation represents the minority of false claims, it garners the majority of social media engagement 2 and is particularly harmful because it adds fuel to a narrative that public health experts and institutions cannot be trusted. Evidence and experience indicate that misinformation about COVID-19 has decreased the public's willingness to support and consistently engage in safety measures designed to mitigate the pandemic, 3 Even prior to the arrival of COVID-19 vaccines, trust in the Food and Drug Administration (FDA) was eroding. The FDA instituted three high profile EUAs for COVID therapies during the pandemic-hydroxychloroquine, chloroquine, and convalescent plasma-each lacking randomized trial data to support their use. Many in the scientific community voiced concern that such rapid EUAs were due to political pressure, a concern reflected in a survey showing that people appear less willing to receive a COVID-19 vaccine approved through an EUA than FDA approval. 7 Similarly, a recent poll by CNN found that, between October 1-to October 4, only 20% of Americans were -very confident‖ that ongoing trials for a COVID-19 vaccine properly balance speed and safety; 40% responded -somewhat confident‖, and 37% -not too confident‖ or -not at all confident‖. 8 Additional political factors have likely contributed to American's distrust of COVID-19 vaccines and left the American public particularly vulnerable to misinformation. Multiple sources indicated that the executive branch sought to exert political influence over the CDC, an independent, science-driven institution. Guidance documents written by CDC staff were A c c e p t e d M a n u s c r i p t 5 reportedly revised under political pressure from the White House, including the recommendation to refrain from testing asymptomatic individuals following an exposure, 9 a decision that was later reversed following pressure from the scientific community; or, reports of interference with the Morbidity and Mortality Weekly Reports, CDC's flagship journal. 10 The arrival of effective SARS-CoV-2 vaccines is a remarkable achievement and could signal an end to the pandemic. But as states and health systems prepare for one of the largest mass vaccination campaigns in US history, these efforts appear to be sailing into a headwind of public opinion. According to a recent Gallup poll conducted between October 19 to November 1, Americans' willingness to receive a SARS-CoV-2 vaccine is 58%; whereas 42% of US adults say they would not willingly receive one. Among those who would not get a vaccine, 37% cite concerns regarding the rushed timeline of vaccine development and 12% lack trust in vaccines in general. 11 Multiple factors undermining public trustmisinformation surrounding COVID-19, a thriving anti-vaccine movement, lack of trust in the FDA, and the sidelining of the CDC-must be mitigated to ensure that efforts to develop, produce, and distribute these vaccines are not wasted.

We believe that broad action across multiple institutions is needed. First, the FDA must improve its communication with the public regarding EUAs for new SARS-CoV-2 therapies and vaccines, and the appearance of political pressure removed. Recent communication by the FDA has been encouraging, including the FDA commissioner's public commitment to releasing the agency's reviews of scientific data supporting the issuance or revocation of EUAs for therapies or vaccines, and FDA's subsequent release of Pfizer and BioNTech's SARS-CoV-2 vaccine efficacy and safety data prior to the advisory committee meeting. 12 Second, the CDC's independence must be restored, and its presence brought back to the front and center of the government's public health response and messaging regarding the COVID-19 pandemic and associated vaccines. Third, SMPs must take a more aggressive stance at moderating COVID-19 and vaccine related misinformation, while curbing the influence of the growing anti-vaccine movement on their platforms. Recent steps taken-such as Facebook's new policies to remove misinformation discouraging people from receiving SARS-CoV-2 vaccines, 13 and broader initiatives launched by multiple SMPs to comprehensively address misinformation surrounding SARS-CoV-2--14 is a good start. M a n u s c r i p t 6 Finally, all of us must do our part to combat misinformation, relying on clear communication that is instilled with compassion and empathy. Physicians and other healthcare professionals remain among the most-trusted groups in our society; now we must use this trust to help ensure that Americans turn to science-based messages, and shun misinformation.

The COVID-19 Social Media Infodemic

Types, sources, and claims of COVID-19

Available online at: Types, sources, and claims of COVID-19 misinformation | Reuters Institute for the Study of Journalism

Effects of Misinformation on COVID-19 Individual Responses and Recommendations For Resilience of Disastrous Consequences of Misinformation

The Anti-Vaccination Movement: A Regression in Modern Medicine

The Golden Age of Anti-Vaccine Conspiracy Theories

The Anti-Vaxx Industry: How Big Tech Powers and Profits From Vaccine Misinformation

Factors Associated With US Adults Likelihood of Accepting COVID-19 Vaccination

Available online at: rel12a.-.coronavirus.pdf (cnn.com)

CDC Testing Guidance Was Published Against Scientists' Objections

Trump Officials Interfered with CDC Reports on COVID-19

Available online at: More Americans Now Willing to Get COVID-19 Vaccine

Vaccine and Related Biological Products Advisory Committee Meeting. December 10, 2020. The Food and Drug Administration. Available online at: Vaccines and Related Biological Products Advisory Committee December 10, 2020 Meeting Briefing Document-FDA

Facebook Says It Will Remove COVID-19 Vaccine Misinformation

YouTube, Facebook, and Twitter Align to fight COVID Vaccine Conspiraries

Funding: No funding was received for this work.

This manuscript did not include factors necessitating patient consent.Potential Conflicts of Interest: JDA receives funding from Arnold Ventures for work unrelated to this manuscript. AN and DD report no conflicts of interest.

M a n u s c r i p t 7 A c c e p t e d M a n u s c r i p t